(Q36162505)

12 August 2017

1 reference

title

Advances in the diagnosis, evaluation, and management of malignant pleural mesothelioma (English)

1 reference

12 August 2017

Daniel H Sterman

1

1 reference

12 August 2017

Steven M Albelda

series ordinal

2

1 reference

12 August 2017

publication date

1 June 2005

1 reference

12 August 2017

1 reference

12 August 2017

volume

10

1 reference

12 August 2017

issue

3

1 reference

12 August 2017

page(s)

266-283

1 reference

Malignant mesothelioma of the pleura

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Continuing increase in mesothelioma mortality in Britain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Malignant mesothelioma due to environmental exposure to asbestos: follow-up of a Turkish cohort living in a rural area.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Incidence of malignant pleural mesothelioma due to environmental asbestos fiber exposure in the southeast of Turkey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

The retinoblastoma gene family pRb/p105, p107, pRb2/p130 and simian virus-40 large T-antigen in human mesotheliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Simian virus (SV) 40 like sequences in cell lines and tumour biopsies from Australian malignant mesotheliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

The value of immunohistochemistry of pleural biopsy specimens in the differential diagnosis between malignant mesothelioma and metastatic carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Immunocytochemical characterization of cell lines from human malignant mesothelioma: characterization of human mesothelioma cell lines by immunocytochemistry with a panel of monoclonal antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Statement on malignant mesothelioma in the United Kingdom

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Gene therapy using adenovirus carrying the herpes simplex-thymidine kinase gene to treat in vivo models of human malignant mesothelioma and lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

The role of imaging in malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Malignant pleural mesothelioma: value of CT and MR imaging in predicting resectability

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Metabolic significance of the pattern, intensity and kinetics of 18F-FDG uptake in malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Positron emission tomography with f18-fluorodeoxyglucose in the staging and preoperative evaluation of malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Prognostic factors for malignant mesothelioma in 142 patients: validation of CALGB and EORTC prognostic scoring systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Phase II trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Use of an implantable pleural catheter for trapped lung syndrome in patients with malignant pleural effusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Surgical treatment of malignant pleural mesothelioma: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Gemcitabine combined with carboplatin in patients with malignant pleural mesothelioma: a multicentric phase II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Using Gene Expression Ratios to Predict Outcome Among Patients With Mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Long-term results of intrathoracic chemohyperthermia (ITCH) for the treatment of pleural malignancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Intrapleural administration of interleukin 2 in pleural mesothelioma: a phase I-II study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

New approaches for mesothelioma: biologics, vaccines, gene therapy, and other novel agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Replication-restricted vaccinia as a cytokine gene therapy vector in cancer: persistent transgene expression despite antibody generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Adenovirus-mediated Bak gene transfer induces apoptosis in mesothelioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Antitumor activity with the HSV-tk-gene-modified cell line PA-1-STK in malignant mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesothelioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

Mesothelin-family proteins and diagnosis of mesothelioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1843.2005.00714.X

10.1111/J.1440-1843.2005.00714.X

21 January 2018

Identifiers

DOI

1 reference

12 August 2017

1 reference